» Articles » PMID: 34290154

Accelerating Towards Human African Trypanosomiasis Elimination: Issues and Opportunities

Overview
Date 2021 Jul 22
PMID 34290154
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT control during the past decade has prompted increasing global dialogue on its elimination and eradication. The disease is targeted by the World Health Organization (WHO) for elimination as a public health problem by 2020 and to terminate its transmission globally by 2030, along-side other Neglected Tropical Diseases (NTD). Several methods have been used to control tsetse flies and the disease transmitted by them. Old and new tools to control the disease are available with constraints. Currently, there are no vaccines available. Efforts towards intervention to control the disease over the past decade have seen considerable progress and remarkable success with incidence dropping progressively, reversing the upward trend of reported cases. This gives credence in a real progress in its elimination. This study reviews various control measures, progress and a highlight of control issues, vector and parasite barriers that may have been hindering progress towards its elimination.

Citing Articles

Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa.

Sinumvayo J, Munezero P, Tope A, Adeyemo R, Bale M, Nyandwi J Vaccines (Basel). 2024; 12(7).

PMID: 39066380 PMC: 11281707. DOI: 10.3390/vaccines12070741.


An and investigation of the antitrypanosomal activities of the stem bark extracts of (Pierre) Engl.

Adams L, Obiri-Yeboah D, Afiadenyo M, Hamidu S, Aning A, Ehun E Heliyon. 2024; 10(6):e28025.

PMID: 38545221 PMC: 10966600. DOI: 10.1016/j.heliyon.2024.e28025.


Structural Modelling of Platelet Activating Factor Acetyl Hydrolase in , , and : Implications on Therapeutics for Leishmaniasis, Chagas Disease, and Sleeping Sickness.

Goswami A, Koley T, Rajan M, Madhuri P, Upadhyay N, Das U Infect Drug Resist. 2023; 16:2117-2128.

PMID: 37070125 PMC: 10105589. DOI: 10.2147/IDR.S403411.


Impact of pulmonary African trypanosomes on the immunology and function of the lung.

Mabille D, Dirkx L, Thys S, Vermeersch M, Montenye D, Govaerts M Nat Commun. 2022; 13(1):7083.

PMID: 36400767 PMC: 9674601. DOI: 10.1038/s41467-022-34757-w.


Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis.

Imran M, Khan S, Alshammari M, Alqahtani A, Alanazi T, Kamal M Pharmaceuticals (Basel). 2022; 15(2).

PMID: 35215241 PMC: 8878566. DOI: 10.3390/ph15020128.